{
    "title": "Pharma giant GSK to withdraw blood cancer drug Blenrep from the US market after key trial failure",
    "url": "https://www.dailymail.co.uk/money/markets/article-11456181/GlaxoSmithKline-withdraw-blood-cancer-drug-US.html",
    "date": "2022-11-22",
    "keywords": [
        "drug",
        "treatment",
        "cancer",
        "month",
        "disease",
        "approval",
        "share",
        "cent",
        "fund",
        "giant",
        "blenrep",
        "trial",
        "time",
        "myeloma",
        "risk",
        "year",
        "investment",
        "account",
        "fee",
        "gsk",
        "blood",
        "usearlier",
        "stage",
        "goal",
        "survival",
        "period",
        "person",
        "type",
        "market",
        "light",
        "sabine",
        "luik",
        "officer",
        "agencys",
        "approach",
        "process",
        "business",
        "babcock",
        "contract",
        "spinoff",
        "haleon",
        "outlook",
        "lung",
        "article",
        "dreamm",
        "programme",
        "work",
        "path",
        "forward",
        "option",
        "today",
        "key",
        "failure",
        "category",
        "profit",
        "demand",
        "vaccine",
        "covid19the",
        "end",
        "capital",
        "isa",
        "trade",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}